These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31629532)

  • 1. The Prevalence, Characteristics, and Patient Burden of Severe Asthma Determined by Using a Japan Health Care Claims Database.
    Sato K; Ohno T; Ishii T; Ito C; Kaise T
    Clin Ther; 2019 Nov; 41(11):2239-2251. PubMed ID: 31629532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and disease burden of severe eosinophilic asthma in Japan.
    Nagasaki T; Sato K; Kume N; Oguma T; Sunadome H; Ito I; Izuhara Y; Okamoto K; Kobayashi S; Ohno T; Mizukami A; Kobayashi A; Kaise T; Kuroda T; Mishima M; Matsumoto H
    J Asthma; 2019 Nov; 56(11):1147-1158. PubMed ID: 30822174
    [No Abstract]   [Full Text] [Related]  

  • 3. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA.
    Suruki RY; Daugherty JB; Boudiaf N; Albers FC
    BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database.
    Lee YJ; Kwon SH; Hong SH; Nam JH; Song HJ; Lee JS; Lee EK; Shin JY
    Clin Ther; 2017 Mar; 39(3):527-536. PubMed ID: 28196623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea.
    Kang HR; Song HJ; Nam JH; Hong SH; Yang SY; Ju S; Lee SW; Kim TB; Kim HL; Lee EK
    BMJ Open; 2018 Mar; 8(3):e020825. PubMed ID: 29567854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data.
    Yokoyama A; Okazaki H; Makita N; Fukui A; Piao Y; Arita Y; Itoh Y; Tashiro N
    Allergol Int; 2022 Jan; 71(1):47-54. PubMed ID: 34493447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy.
    Schatz M; Meckley LM; Kim M; Stockwell BT; Castro M
    J Allergy Clin Immunol Pract; 2014; 2(5):570-4.e1. PubMed ID: 25213050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world treatment and health care resource use among severe asthma patients in Japan.
    To Y; Taguchi Y; Shimazaki T; Arima K; Yu E; Sven D; Iwanaga T
    Respir Investig; 2021 Jul; 59(4):464-477. PubMed ID: 33789828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan.
    Nagase H; Adachi M; Matsunaga K; Yoshida A; Okoba T; Hayashi N; Emoto K; Tohda Y
    Allergol Int; 2020 Jan; 69(1):53-60. PubMed ID: 31311707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
    Ivanova JI; Bergman R; Birnbaum HG; Colice GL; Silverman RA; McLaurin K
    J Allergy Clin Immunol; 2012 May; 129(5):1229-35. PubMed ID: 22326484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    PLoS One; 2020; 15(5):e0232738. PubMed ID: 32442204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation risk and characterisation of the UK's asthma population from infants to old age.
    Bloom CI; Nissen F; Douglas IJ; Smeeth L; Cullinan P; Quint JK
    Thorax; 2018 Apr; 73(4):313-320. PubMed ID: 29074814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
    Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
    Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease burden in patients with asthma before initiating biologics: A retrospective cohort database study.
    Ortega H; Hahn B; Tran JN; Bell C; Shams SA; Llanos JP
    Allergy Asthma Proc; 2019 May; 40(3):146-153. PubMed ID: 30925945
    [No Abstract]   [Full Text] [Related]  

  • 15. Impacts of coexisting bronchial asthma on severe exacerbations in mild-to-moderate COPD: results from a national database.
    Lee H; Rhee CK; Lee BJ; Choi DC; Kim JA; Kim SH; Jeong Y; Kim TH; Chon GR; Jung KS; Lee SH; Price D; Yoo KH; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():775-83. PubMed ID: 27143869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of asthma severity according to treatment steps in Japanese pediatric patients: a descriptive cross-sectional study using an administrative claims database.
    Yoshida S; Tanaka S; Adachi Y; Yoshisue H; Kozawa M; Kawakami K
    J Asthma; 2021 Dec; 58(12):1574-1580. PubMed ID: 32900270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geographic variation in disease burden among patients with severe persistent asthma in the United States.
    Camargo CA; Rane PB; Beck AF; Wang Y; Chung Y; McGuiness CB; Llanos JP; Lindsley AW; Ambrose CS; Zhou Z; Chang HC; Wade RL
    Ann Allergy Asthma Immunol; 2024 May; 132(5):602-609.e4. PubMed ID: 38141810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Clinical Characteristics of Patients with Moderate-to-Severe Asthma in Japan Using a JMDC Claims Database.
    Wang D; Ito C; Homma Y; Arimitsu M; Yoshisue H
    Int Arch Allergy Immunol; 2023; 184(7):698-706. PubMed ID: 36796345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of asthma exacerbations and health care utilization in pediatric patients with asthma in the US and England.
    Gokhale M; Hattori T; Evitt L; Lenney W; Nordstrom B; Collins J; Schultze A; Van Dyke MK
    Immun Inflamm Dis; 2020 Jun; 8(2):236-245. PubMed ID: 32222038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory research on asthma exacerbation risk factors using the Japanese claims database and machine learning: a retrospective cohort study.
    Hozawa S; Maeda S; Kikuchi A; Koinuma M
    J Asthma; 2022 Jul; 59(7):1328-1337. PubMed ID: 33926352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.